CareDx Inc
(FRA:1K9)
€
21.22
0.03 (0.14%)
Market Cap: 1.12 Bil
Enterprise Value: 934.77 Mil
PE Ratio: 0
PB Ratio: 4.59
GF Score: 71/100 CareDx Inc at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023 / 11:40PM GMT
Release Date Price:
€7.65
(+1.32%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Hi. Good afternoon, everyone. Thanks for joining us. My name is Matt Sykes. I'm the Life Science Tools & Diagnostics analyst at Goldman Sachs, and I have the pleasure of having the senior management team from CareDx joining me today. Reg Seeto, President and CEO; Abhishek Jain, CFO; and Robert Woodward, Senior Vice President, R&D.
Reg, Abhishek and Robert, thank you very much for joining us.
Reginald Seeto
CareDx, Inc - President, CEO & Director
Thank you, Matt. Thanks for (inaudible)
Questions & Answers
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Maybe I think it would be helpful for you, Reg, to kind of set the stage first. Maybe for the benefit of the audience, talk a little bit about where -- who CareDx is, markets you serve and then kind of some of the trends that you're seeing in your business and over the course of this year.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot